Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 120

    Zydus gets USFDA nod for Omega-3-Acid Ethyl Esters capsules

    Zydus gets USFDA nod for Omega-3-Acid Ethyl Esters capsules

    Farhat Nasim15 Jun 2019 2:46 PM IST
    Omega-3-acid ethyl esters, a type of fat found in fish oil, is used along with diet and exercise to help lower levels of certain blood fat...
    Biocon gets European nod for biologics facilities in Bengaluru

    Biocon gets European nod for biologics facilities in Bengaluru

    Medical Dialogues Bureau15 Jun 2019 11:18 AM IST
    The biotechnology major has received the certificate for its biologics drug product and drug substance facilities at Biocon Park, Bengaluru, the...
    Data integrity lapse at Aurobindo Pharma Bachupally Unit, says USFDA

    Data integrity lapse at Aurobindo Pharma Bachupally Unit, says USFDA

    Medical Dialogues Bureau15 Jun 2019 11:17 AM IST
    Aurobindo Pharma received Form 483 with 11 observations for one of its units located in a Special Economic Zone in Telangana earlier this year. New...
    Dr Reddys to sell Tosymra, Zembrace to Upsher-Smith Labs for Rs 765 crore approx

    Dr Reddys to sell Tosymra, Zembrace to Upsher-Smith Labs for Rs 765 crore approx

    Farhat Nasim15 Jun 2019 10:00 AM IST
    Dr Reddy's (Dr Reddys) Labs said Tosymra and Zembrace were designed and developed with the goal of addressing unmet needs of large but discrete...
    Bayer to invest $5.6 billion in weedkilling research

    Bayer to invest $5.6 billion in weedkilling research

    Medical Dialogues Bureau15 Jun 2019 9:15 AM IST
    "While glyphosate will continue to play an important role in agriculture and in Bayer's portfolio, the company is committed to offering more choices...
    US cities pitch framework for nationwide opioid settlement talks

    US cities pitch framework for nationwide opioid settlement talks

    Medical Dialogues Bureau15 Jun 2019 9:00 AM IST
    U.S: Lawyers for counties and municipalities suing drug manufacturers and distributors over their alleged roles in the U.S. opioid epidemic on Friday...
    GSK forms drug discovery alliance with University of California CRISPR researchers

    GSK forms drug discovery alliance with University of California CRISPR researchers

    Medical Dialogues Bureau14 Jun 2019 12:24 PM IST
    British drugmaker GSK said it has struck a research deal with the early pioneers of a prominent gene-editing technology at the University of...
    Wockhardt gets zero observations from USFDA for bioequivalence centre at Aurangabad

    Wockhardt gets zero observations from USFDA for bioequivalence centre at Aurangabad

    Medical Dialogues Bureau14 Jun 2019 10:30 AM IST
    During the inspection, bioanalytical and quality systems of bioequivalence studies of Tamsulosin 0.4 mg capsules and Metoprolol ER tablets were...
    IBM, Walmart, Merck in blockchain collaboration with FDA

    IBM, Walmart, Merck in blockchain collaboration with FDA

    Medical Dialogues Bureau14 Jun 2019 9:41 AM IST
    IBM, Merck and Walmart have been chosen for a U.S. Food and Drug Administration pilot program that will explore using blockchain technology to improve...
    Amgen drug shows high response rate in small lung, colon cancer trial

    Amgen drug shows high response rate in small lung, colon cancer trial

    Medical Dialogues Bureau14 Jun 2019 9:15 AM IST
    Wall Street has taken a keen interest in the Amgen drug that could become the first approved medicine targeting a mutated form of a gene known as KRAS...
    Canadian advisory council calls for universal public drug coverage

    Canadian advisory council calls for universal public drug coverage

    Medical Dialogues Bureau14 Jun 2019 9:00 AM IST
    The council said a national drug agency should be created first, with coverage for essential medicines in place by January 1, 2022.OTTAWA: A Canadian...
    Novartis

    Novartis' secret settlement talks revealed in accidental filing: Bloomberg Report

    Medical Dialogues Bureau13 Jun 2019 10:03 AM IST
    The U.S. sued the Novartis six years ago, joining in a case filed by a former sales representative who accused the company of using its speaker's...
    PrevNext

    Popular Stories

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance

    MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok